Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
NCT ID: NCT05731661
Last Updated: 2026-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
99 participants
INTERVENTIONAL
2023-01-09
2027-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is expected that an evaluation of the needs for supportive oncology care and its organization in day hospitalization for supportive oncology care will lead to an improvement in personalized post-cancer follow-up for these patients and to an improvement in their long-term quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
NCT06553612
Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
NCT02412124
Development and Evaluation of a Fertility Preservation Patient Decision Aid for Women With Cancer.
NCT02753296
Reproductive Health Survivorship Care Plan
NCT02667626
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
NCT02323568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Delivery of a Personalized Post-Cancer Plan (PPAC) with a day hospitalization in supportive care
Day hospitalization in support care with meeting with support care professionals and coordination of actions by the advanced practice nurse
During this day hospitalization, patients will meet with different specialized professionals depending on the support care needs identified.
Delivery of a personalized post-cancer plan
Delivery of a personalized post-cancer plan
Delivery of a Personalized Post-Cancer Plan (PPAC) without day hospitalization in supportive care
Delivery of useful information according to support care needs, concerning support care professionals in the city
Delivery of useful information according to support care needs, concerning support care professionals in the city
Delivery of a personalized post-cancer plan
Delivery of a personalized post-cancer plan
Observational cohort
Delivery of a personalized post-cancer plan
Delivery of a personalized post-cancer plan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Day hospitalization in support care with meeting with support care professionals and coordination of actions by the advanced practice nurse
During this day hospitalization, patients will meet with different specialized professionals depending on the support care needs identified.
Delivery of useful information according to support care needs, concerning support care professionals in the city
Delivery of useful information according to support care needs, concerning support care professionals in the city
Delivery of a personalized post-cancer plan
Delivery of a personalized post-cancer plan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient in complete remission after first-line treatment for endometrial or ovarian/fallopian tube/peritoneal cancer
* Patient having completed her initial treatment; patients with maintenance treatments are eligible
* Mastery of the French language
* Patient with a telephone line
* Patient affiliated to a social security scheme
* Signature of informed consent before any specific procedure related to the study
Exclusion Criteria
* Patient with locoregional or metastatic recurrence
* Patient deprived of liberty, under guardianship or curatorship
* Simultaneous participation in a therapeutic clinical trial
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ligue contre le cancer, France
OTHER
Centre Francois Baclesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Francois Baclesse
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A01872-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.